Yosprala (Aspirin and Omeprazole Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 18, 2017 Category: Drugs & Pharmacology Source Type: news

Can You Develop a Tolerance for Prilosec?
Title: Can You Develop a Tolerance for Prilosec?Category: Doctor's& Expert's views on SymptomsCreated: 9/18/2017 12:00:00 AMLast Editorial Review: 9/18/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - September 18, 2017 Category: Nutrition Source Type: news

Heartburn drugs like Nexium and Prilosec don't raise Alzheimer's risk: study
Widely used heartburn drugs, including Prilosec and Nexium, do not appear to increase Alzheimer's disease risk, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 19, 2017 Category: Consumer Health News Source Type: news

Popular Heartburn Drugs Don't Raise Risk of Alzheimer's: Study
Researchers say proton pump inhibitors like Nexium or Prilosec not linked to dementia (Source: WebMD Health)
Source: WebMD Health - August 18, 2017 Category: Consumer Health News Source Type: news

Popular Heartburn Drugs Don't Raise Risk of Alzheimer's
Researchers say proton pump inhibitors like Nexium or Prilosec not linked to dementia Source: HealthDay Related MedlinePlus Pages: Alzheimer's Disease, Drug Safety, Heartburn (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 18, 2017 Category: Consumer Health News Source Type: news

Popular Heartburn Drugs Don't Raise Risk of Alzheimer's: Study
FRIDAY, Aug. 18, 2017 -- Widely used heartburn drugs called proton pump inhibitors do not appear to increase Alzheimer ' s disease risk, according to a new study. Prilosec, Nexium and Prevacid are commonly used proton pump inhibitors. Two previous... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 18, 2017 Category: General Medicine Source Type: news

Heartburn drugs linked to premature death
Conclusion This larger set of observational data finds that PPI drugs are associated with an increase in the risk of early death compared with either H2 blockers or no acid suppression drugs. This was the case for participants both with and without gastrointestinal problems. It also appears as though the longer the PPIs drugs are taken, the greater the risk of death. Considering that these drugs are widely used in the UK, these findings may cause concern. But the research has a number of important limitations: The study was conducted in a population of mostly white, older US male veterans, which might limit the abilit...
Source: NHS News Feed - July 4, 2017 Category: Consumer Health News Tags: Medication Source Type: news

Some heartburn drugs linked with higher risk of death
Study looked at patients who'd taken proton pump inhibitors, or PPIs, including popular brands like Prilosec, Nexium and Prevacid (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 4, 2017 Category: Consumer Health News Source Type: news

Study: Heartburn meds could shorten life span
Popular heartburn medications like Nexium, Prilosec or Prevacid may increase your risk of early death when taken for extended periods, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 4, 2017 Category: Consumer Health News Source Type: news

Can Your Heartburn Meds Shorten Your Life?
MONDAY, July 3, 2017 -- Popular heartburn medications like Nexium, Prilosec or Prevacid may increase your risk of early death when taken for extended periods, a new study suggests. Further, the longer you take these drugs, known as proton pump... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 3, 2017 Category: General Medicine Source Type: news

Zegerid (Omeprazole, Sodium Bicarbonate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 3, 2017 Category: Drugs & Pharmacology Source Type: news

Torax Medical touts preliminary results from Linx GERD study
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon‘s Torax Medical business today released results from the Caliber trial of its Linx system for treating gastro-esophageal reflux disease, touting quality of life improvements and reduction in reflux levels. The Linx system is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier function to prevent reflux in patients with gastro-esophageal reflux disease, the company said. Data from the trial was presented at the Digestive Disease Week 2017 meeting in Chicago. The randomized, controlled, 150-patient C...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Otolaryngology Ear, Nose & Throat Ethicon Johnson & Johnson Torax Medical Inc. Source Type: news

Prilosec (omeprazole) vs. Nexium (esomeprazole)
Title: Prilosec (omeprazole) vs. Nexium (esomeprazole)Category: MedicationsCreated: 3/30/2017 12:00:00 AMLast Editorial Review: 3/30/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 30, 2017 Category: Drugs & Pharmacology Source Type: news